| The integrated genomic landscape of thymic epithelial tumors M Radovich, CR Pickering, I Felau, G Ha, H Zhang, H Jo, KA Hoadley, ... Cancer cell 33 (2), 244-258. e10, 2018 | 309 | 2018 |
| Elevated protein kinase C βII is an early promotive event in colon carcinogenesis Y Gökmen-Polar, NR Murray, MA Velasco, Z Gatalica, AP Fields Cancer research 61 (4), 1375-1381, 2001 | 241 | 2001 |
| Protein kinase Cι is required for Ras transformation and colon carcinogenesis in vivo NR Murray, L Jamieson, W Yu, J Zhang, Y Gökmen-Polar, D Sier, ... The Journal of cell biology 164 (6), 797-802, 2004 | 185 | 2004 |
| HSF1 as a cancer biomarker and therapeutic target RL Carpenter, Y Gökmen-Polar Current cancer drug targets 19 (7), 515-524, 2019 | 102 | 2019 |
| EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity M Lu, KD Miller, Y Gokmen-Polar, MH Jeng, MS Kinch Cancer research 63 (12), 3425-3429, 2003 | 100 | 2003 |
| DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer S Woditschka, L Evans, R Duchnowska, LT Reed, D Palmieri, Y Qian, ... JNCI: Journal of the National Cancer Institute 106 (7), dju145, 2014 | 82 | 2014 |
| Ductal carcinoma in situ of breast: update 2019 SS Badve, Y Gökmen-Polar Pathology 51 (6), 563-569, 2019 | 78 | 2019 |
| Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients R Duchnowska, J Jassem, CP Goswami, M Dundar, Y Gökmen-Polar, L Li, ... Journal of Neuro-oncology 122, 205-216, 2015 | 78 | 2015 |
| Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models Y Gökmen-Polar, Y Liu, RA Toroni, KL Sanders, R Mehta, S Badve, ... Breast cancer research and treatment 136, 673-682, 2012 | 76 | 2012 |
| Extrathoracic metastases of thymic origin: a review of 35 cases T Vladislav, RK Jain, R Alvarez, RJ Mehta, Y Gökmen-Polar, KA Kesler, ... Modern Pathology 25 (3), 370-377, 2012 | 75 | 2012 |
| Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model R Shanmugam, V Jayaprakasan, Y Gokmen‐Polar, S Kelich, KD Miller, ... The Prostate 66 (14), 1498-1511, 2006 | 73 | 2006 |
| CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer KE Craven, Y Gökmen-Polar, SS Badve Scientific Reports 11 (1), 4691, 2021 | 67 | 2021 |
| Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers Y Gökmen-Polar, IT Vladislav, Y Neelamraju, SC Janga, S Badve Scientific reports 5 (1), 8765, 2015 | 67 | 2015 |
| Splicing factor ESRP1 controls ER‐positive breast cancer by altering metabolic pathways Y Gökmen‐Polar, Y Neelamraju, CP Goswami, Y Gu, X Gu, G Nallamothu, ... EMBO reports 20 (2), e46078, 2019 | 63 | 2019 |
| Protein kinase C-β as a therapeutic target in breast cancer GW Sledge Jr, Y Gökmen-Polar Seminars in oncology 33, 15-18, 2006 | 61 | 2006 |
| Mapping of a molecular determinant for protein kinase C βII isozyme function Y Gökmen-Polar, AP Fields Journal of Biological Chemistry 273 (32), 20261-20266, 1998 | 61 | 1998 |
| Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer Y Gökmen-Polar, RA Toroni, BA Hocevar, S Badve, Q Zhao, C Shen, ... Breast cancer research and treatment 127, 375-384, 2011 | 55 | 2011 |
| Single-cell heterogeneity in ductal carcinoma in situ of breast MJ Gerdes, Y Gökmen-Polar, Y Sui, AS Pang, N LaPlante, AL Harris, ... Modern Pathology 31 (3), 406-417, 2018 | 54 | 2018 |
| Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer Y Gökmen-Polar, Y Neelamraju, CP Goswami, X Gu, G Nallamothu, ... Modern pathology 28 (5), 677-685, 2015 | 54 | 2015 |
| The role of histology in predicting recurrence of type A thymomas: a clinicopathologic correlation of 23 cases IT Vladislav, Y Gökmen-Polar, KA Kesler, PJ Loehrer Sr, S Badve Modern Pathology 26 (8), 1059-1064, 2013 | 52 | 2013 |
